PHARMANIAGA |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.34 MYR | +1.49% |
|
+1.49% | -11.69% |
| Apr. 19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
| Mar. 27 | Pharmaniaga Berhad Appoints Tuan Drs. Imam Fathorrahman as Independent and Non Executive Member of Audit Committee | CI |
Evolution of the average Target Price on Pharmaniaga
Price target over the last 5 years
History of analyst recommendation changes
69fc0a0bd13b4cea2c3c4d7.toZnKU8AcqGCG8Xu64UpK-EBybbjQ4UXey7btXgDxoY._e0BGx5rOtbWL7evndRRbr4xq9W1Fbd2NFiU5Ahqh-nu3gBvA1cQmORLjA~38e6228ff292764176c5dab0440e2c69
Analysts' Consensus
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.34
MYR
Average target price
0.31
MYR
Spread / Average Target
-8.82%
High Price Target
0.31
MYR
Spread / Highest target
-8.82%
Low Price Target
0.31
MYR
Spread / Lowest Target
-8.82%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHARMA Stock
- Consensus Pharmaniaga
